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Abstract 
Intensive care faces economic challenges. Therefore evidence proving both 
effectiveness and efficiency, i.e. cost-effectiveness, of delivered care is needed. Today, 
the quality of care is an important issue in the health care debate. How do we 
measure quality of care, and how accurate and representative is this measurement? 
In the following report several topics, which are used for the evaluation of ICU 
performance, are discussed: (1) The use of general outcome prediction models to 
assess/ quantify the risk of patients who are admitted to our ICUs in an increasing 
variety in case mix for all the different intensive care units. Together with three major 
limitation; (2) As critical care outcomes research becomes a more established entity 
mortality is now only one of many endpoints that are of relevance. Mortality is a 
limited outcome when assessing critical care performance, while patient interest in 
QoL outcomes is of relevance; and (3) The Quality Indicators Committee of the 
Society of Critical Care Medicine recommended that short-term readmission is a 
leading performance indicator of the quality of intensive care medicine. 
 
Key words: Intensive care performance; Quality of Care; Critical Care; Intensive Care 
Medicine 
Core tip: Variations in case-mix, ICU demographics, clinical and non-clinical factors 
not addressed by the present severity of illness scores must be quantified to improve 
the accuracy of future prediction models. A completely different benefit, in the use of 
HrQoL as a performance-benchmark, could be the possibility of follow-up evaluation 
of the patients’ health status after ICU or hospital discharge. The moment when 
outcome research can predict the short-term (ICU discharge) QoL of a critically ill 
patient during the first 24 h of ICU admission; It will give physicians and health care 
policy makers an up-to-date and reliable evaluation of quality of care in the ICU 
during the upcoming years. 
 INTRODUCTION 
The intensive care unit (ICU) is a hospital unit providing continuous surveillance 
and highly specialized care to critically ill patients, either medical or surgical. 
Patient’s conditions are life-threatening and require comprehensive care. Established 
approximately five decades ago, the ICU is now an essential part of hospital care. It 
presents itself as the discipline that aims to help patients with extended needs of care 
and organ support.  
Intensive care faces economic challenges. Therefore, evidence proving both 
effectiveness and efficiency, i.e. cost-effectiveness, of delivered care is needed. ICUs 
consume a significant proportion of health care resources, accounting for up to 20% 
of a hospital’s cost [1-6]. By 2005, critical care medicine (CCM) costs in the United 
States were estimated to be $81.7 billion accounting for 4.1% of the national health 
expenditures, 0,66% of the gross domestic product. The US spends 15% of the gross 
domestic product on healthcare (9-11% in Germany, France and Canada; 7-8% in 
Spain and the United Kingdom). Intensive care costs are predicted to grow all over 
the developed world [2,5,7-14].  
Today, quality of care is an important issue in the health care debate. All countries 
struggle to optimize quality of care while minimizing costs. Evaluation of clinical 
performance is a prerequisite for the assessment of both the effectiveness and 
efficiency of care [15] and, therefore, several questions arise: How do we measure 
quality of care, and how accurate and representative is this measurement?   
 
The goal of intensive care medicine is to achieve the best outcome for critically ill 
patients, and usually this is accompanied by the use of very complex care [16]. All 
patients carry both an intrinsic risk (disease-related) and an extrinsic risk (care-
related) at the same time [16,17]. There is an ever-increasing recognition of the wide 
variation in the quality of care across ICUs and its effect on outcome. Indicators to 
evaluate the quality of care are increasingly being used and focus on patient outcome 
[18]. Finding a reliable method to quantify the performance of single ICUs has been a 
difficult quest in the last 30 years.  
 
Outcome prediction models: shall we continue in the same way? 
Each new development in critical care treatment over the past 30 years has been 
implemented to improve the quality of care. Therefore, the extrinsic risks that 
patients carry should be as low as possible. Ideally, quality of care performance 
research should give more information about the extrinsic risks rather than the 
intrinsic ones. At this moment, ICU performance evaluation is becoming increasingly 
difficult because of the presence of an increasing variety in patient case mix for all the 
different intensive care units. Since the development of prediction mortality models 
in the early 1980s, physicians have tried to normalize certain different ICU 
populations through the use of severity of illness measurements. At the time that a 
general outcome prediction model (GOPM) had been developed the intrinsic risk 
had been adjusted in such a way that performance mainly illuminates the extrinsic 
risk factors. Most published approaches, concerning the evaluation of ICU 
performance, adopt more or less the same procedures: the development of a GOPM 
and its calibration in a suitable database. Such models are then applied to different 
cohorts of ICU patients, and the comparison of the predicted number of deaths with 
the actual number is used as a reference for the clinical performance of the unit [15]. 
For more than 30 years, outcome research in critical care relied heavily on these risk 
adjustment methods (GOPM) to assess and quantify the risk of patients who are 
admitted to our ICUs. Using several GOPMs this methodology has become the ‘gold 
standard’ to compare ICUs across different geographical areas, or within a specific 
individual nation, or other specific subgroups. Several risk adjustment systems have 
been developed or have undergone an update and are used in daily practice.  
In the use of general outcome prediction models, several limitations should be 
considered.  
1. Most systems give a single estimate, known as the standardized mortality 
ratio (SMR). A single estimate considers that the performance of an ICU is constant 
over the whole spectrum of the severity of illness [19]. In other words, an ICU with a 
‘good’ performance (low SMR) is assumed to be uniformly good for both low-risk 
and high-risk patients; likewise, an ICU with a ‘bad’ performance (high SMR) is 
assumed to be uniformly bad. However, since performance can vary not only 
between ICUs but also within the same unit across patients and doctors, this 
assumption is likely not true [15]. Several studies have provided conclusive evidence 
that the clinical performance of ICUs may vary over the spectrum of severity of 
illness [15,16,20-23]. 
2. It is unknown whether variations in SMR reflect quality of care or case mix 
differences. Debate continues whether higher than predicted mortality (high SMR) is 
a warning about the quality of care or rather reflects a difference of case mix between 
hospitals [24]. In the past, GOPMs have been revised or even updated to newer 
versions to predict expected death more accurately. However, before a new GOPM 
version is used, many years have elapsed. Although, the newer third and fourth 
versions of the APACHE prognostic model were developed many years ago [25-27], the 
APACHE II score is still one of the prediction models most widely used [12,28].  
3. There is no consensus which GOPM must be used for which type of ICU 
(general mixed unit, specialized unit, or even in different sub-populations). For 
critical care physicians there are three overall GOPMs for predicting overall mortality 
and used for performance evaluations: the APACHE model [25-27,29], the MPM system 
[30-32] and the SAPS model [22,23,33-35]. These scoring systems differ in the choice and the 
relative weight given to patient characteristics and physiological parameters [18]. 
Quality of care performance evaluation should be done with the same - and ideally 
most reliable - outcome prediction model for each intensive care unit. Because there 
is no consensus which GOPM should be used, they seem to be used randomly. 
Within the Netherlands, this last item has been addressed: Since the year 2008, all 61 
participating ICUs in the NICE registry started using the APACHE IV prognostic 
model. 
 
The quality of intensive care performance. 
Until today, one of the most used ICU performance measurements is the 
standardized mortality ratio (SMR). The SMR has been developed in a period that 
the evaluation of quality of care was done exclusively through primary patient 
outcome (short-term mortality). Some authors have evaluated the use of SMR as an 
indicator of ICU quality of care and debated its specific relevance [17,36,37]. The SMR 
value gives insight in the observed mortality compared with the associated predicted 
mortality, but it does not gives insight in the health status of these patients.  
As critical care outcomes research becomes a more established entity mortality is 
now only one of many endpoints that is of relevance, and mortality is a limited 
outcome evaluation method when assessing critical care performance. The health-
related quality of life (HrQoL), defined as the degree to which a patient’s health 
status affects the subjective evaluation of his or her satisfaction with life, seems to be 
a better indicator, especially from the patient-centred view [38]. ICU and hospital 
survival will always have an important role in the evaluation of performance at the 
moment different units or hospitals are being benchmarked. Consequently, in the last 
decennia the quality of life (QoL) has gained great interest when not only physicians 
but also the patients’ relatives mention patient outcome. Therefore, QoL clearly 
challenges survival whenever we address secondary (long-term) patient outcome.  
 
Difficulties are being foreseen when using health status as a performance-benchmark 
[39], because of the great diversity in intrinsic risk that patients carry in all the 
different ICUs (i.a. specialized units, general mixed units). How should we use 
health status as performance-benchmark? Should we cross-section the mean health 
status of a given cohort against the general population norm, or must we compare 
individual outcome with individual pre-admission values? The latter will invariably 
provide more patient oriented and thus clinically relevant outcome values, but also 
result in an administrative burden. A third possibility is to compare such an 
individual QoL value with a predicted individual health status.  
The ability to predict a patient’s QoL after ICU admission could be useful in many 
ways. Firstly, it could help patients and their relatives to make decisions. Secondly, it 
could help families to prepare themselves to care for the patient after hospital 
discharge. Thirdly, it could help critical care physicians to give useful information, 
avoid unrealistic expectations, and - possibly – could help in making treatment 
decisions. Fourthly, it could help society to realize in which ICUs patients have a 
good chance of recovery and give health policy makers and insurance companies the 
insight in the needs of ICUs [39,40].  
A completely different benefit, in the use of HrQoL as a performance-benchmark, 
could be the possibility of follow-up evaluation of patients’ health status after ICU or 
hospital discharge. Post-ICU patients are known to express a reduced HrQoL 
compared to the general population. It is still not clear to what extend and how long 
this reduced HrQoL persists, although this effect may be long-lasting [41]. Therefore, a 
continuous survey as part of regular after care for each individual patient, would be 
the ideal way to investigate this, and gives the possibility to better manage patients 
in which HrQoL does not increase as expected.  
 
Readmission to the ICU: Can we predict patients at risk for readmission? 
The Quality Indicators Committee of the Society of Critical Care Medicine 
recommended that readmission within 48 hours is a leading performance indicator of 
the quality of intensive care medicine [42]. Readmitted patients are most often the 
sickest in the ICU; therefore, it is an unexpected and unfavourable event for the 
patient, and is associated with a more severe outcome [43-52]. Moreover, a strategy to 
reduce premature discharges in patients at high risk of in-hospital death could result 
in a reduction of post-ICU mortality (Daly et al.: 39% reduction in mortality) [52-54]. In 
times of great pressure on the ICU capacity, should we not be more careful in 
deciding which patient may be discharged and who has a greater risk of 
readmission? Ideally, such decisions are made on sound criteria, rather than 
subjective parameters. In the last 10 years several authors have proven that it is 
difficult to analyze and predict readmittance-risk for ICU patients in general [44-47]. 
Various authors concluded that patients readmitted to the ICU had a higher severity 
of illness score at the time of initial ICU discharge compared to single ICU admission 
patients [45,46,55]. Ideally perhaps, severity of illness is scored on a daily base and 
discharge is initiated from these values. Unfortunately, these severity of illness scores 
have not been validated after the first 24 hours of ICU admission. The Sequential 
(Sepsis-related) Organ Failure Assessment score (SOFA score), is used to track a 
patient’s status during the admission in the ICU (also validated to be used after 24 
hours). The SOFA score is a scoring system to determine the extent of a person’s 
organ function or rate of failure [56-59]. This particular score has been validated to 
predict ICU mortality [60]. Nevertheless, the possible association with readmission has 
not been evaluated as yet. Currently, there are hardly any systematic studies of how 
daily severity of illness score changes from admission to initial discharge predict ICU 
readmission [28,47]. Besides the severity of illness score there is also an association 
between nursing workload and post-ICU mortality [61,62]. The Therapeutic 
Intervention Scoring System (TISS) has been widely applied to assess workload and 
resource allocation in intensive care, measuring treatment intensity [63]. 
Consequently, attempts have been made to use TISS scores to categorize the level of 
care that patients require, even to evaluate the care required after ICU discharge 
[64,65]. Several authors have shown an association of the TISS value of the last ICU day 
with post-ICU mortality [61,62,66,67], and therefore, indirectly, the association with ICU-
readmission. Smith et al. concluded in their research that the mean TISS scores in 
patients readmitted to the ICU were significantly higher than in patients who did not 
require readmission [62].  
Since a couple of years Spanish physicians have shown great interest in this topic and 
developed the Sabadell score system, a modification of the McCabe score [68-70]. They 
have validated the applicability of the Sabadell score as a system for classifying 
patients’ ward survival at discharge from the ICU [71]. They even found an 
association of the Sabadell score with ICU readmission. Unfortunately, the lack of 
reliable predictors of ICU readmission precludes the clinical usefulness of this 
variable. However, this information may improve the ability to predict the readiness 
for discharge for individual patients and improve the efficiency of intensive care 
units. Would critical care physicians have more information about patients’ disease-
status when they use a combination of several systems (TISS, severity of illness score 
and Sabadell score) as prediction measurement for ICU discharge readiness? This 
value could also give an indication if the patient could be discharged to the normal 
ward or that he should first be admitted to a step-down unit (high dependency unit).  
 
Hospital death rates would be particularly useful if patients and physicians could 
use the statistics for a given diagnosis to select a hospital that offers the best prospect 
of survival. If the data are only partially corrected for differences in the health status 
of patients, then they must be used with caution [19]. Variations in case-mix, ICU 
demographics, clinical and non-clinical factors not addressed by the present severity 
of illness scores must be quantified to improve the accuracy of future prediction 
models. If the variation between ICUs is important, it will impair the stability of the 
equations used to compute predicted mortality and preclude the use of indirect 
standardization in the evaluation of differences between ICUs. These GOPMs 
consider the relation between performance and severity of illness as constant, 
although performance can vary within ICUs according to the degree of severity of 
illness in patients. Hypothetically, performance should be evaluated through the 
combination of survival (SMR) and the health status (QoL) at the time of discharge. 
As yet, this combination of both outcome measurements has not been used in a 
single benchmark value. Therefore, future research should focus on predicting 
quality of life together with an accuracy study of the TISS, severity of illness and the 
Sabadell scores to identify and weigh the specific variables for readmission. The 
moment when outcome research can predict the short-term (ICU discharge) QoL of a 
critically ill patient during the first 24 hours of ICU admission; It will give physicians 
and health care policy makers an up-to-date and reliable evaluation of quality of care 
in the ICU during the upcoming years. 
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